Aliza Ahmed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aliza Ahmed has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Hassan Saeed
Department of Medicine, Jinnah Postgraduate Medical Center, Karachi, Pakistan
6 shared publications - Aisha Imran
Jinnah Sindh Medical University, Karachi, Pakistan
1 shared publication - Aleeza Abid
Jinnah Sindh Medical University
1 shared publication Farah Shaikh
Jinnah Post Graduate Medical Centre, Karachi, Pakistan
1 shared publication- Ihsan Qamar
Faculty of Medicine, Spinghar University, Kabul, Afghanistan
1 shared publication Mubashira Noor
Jinnah Sindh Medical University, Karachi, Pakistan
1 shared publication
Latest Publications
- 26 October 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (11) , e70509
Clarifying Age Stratification and Mechanisms of Early Kidney Graft Loss in Young Recipients
- 26 October 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (11) , e70509
Clarifying Age Stratification and Mechanisms of Early Kidney Graft Loss in Young Recipients
- Open Access
- 26 October 2026
- Published by BMJ in BMJ Open Quality
- Vol. 15 (4) , e004563
Timeliness versus diagnostic accuracy in ICU pneumonia sampling: is ND-BAL ready for broader adoption?
In this timely quality-improvement study, Lewis et al describe a non-directed bronchoalveolar lavage (ND-BAL) intervention that increased early respiratory sampling within 6 hours of intensive care unit (ICU) admission, reduced oral flora contamination compared with endotracheal aspirates (ETAs) and increased Legionella testing among mechanically ventilated patients with suspected community-acquired pneumonia (CAP).1 The principal contribution of this work lies not in the introduction of ND-BAL itself, but in the incorporation of the procedure into routine ICU management.
- 26 October 2026
- Published by BMJ in BMJ Open Quality
- Vol. 15 (4) , e004563
Open AccessTimeliness versus diagnostic accuracy in ICU pneumonia sampling: is ND-BAL ready for broader adoption?
In this timely quality-improvement study, Lewis et al describe a non-directed bronchoalveolar lavage (ND-BAL) intervention that increased early respiratory sampling within 6 hours of intensive care unit (ICU) admission, reduced oral flora contamination compared with endotracheal aspirates (ETAs) and increased Legionella testing among mechanically ventilated patients with suspected community-acquired pneumonia (CAP).1 The principal contribution of this work lies not in the introduction of ND-BAL itself, but in the incorporation of the procedure into routine ICU management.
- Open Access
- 14 May 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (6) , 3404-3410
Zoliflodacin for uncomplicated gonorrhea: clinical evidence and implications beyond ceftriaxone plus azithromycin
Background: Globally, gonorrhea remains a common sexually transmitted infection that can lead to serious sexual and reproductive health complications if left untreated. Management has become more challenging due to the rapid progression of antimicrobial resistance in Neisseria gonorrhoeae . Currently, ceftriaxone-based regimens continue to be the standard treatment; however, the sudden demand for new treatment options is highlighted by concerns regarding resistance, the requirement for intramuscular administration, and the declining effectiveness of azithromycin. Objective: This review aims to evaluate the emerging role of zoliflodacin in the treatment of gonorrhea, with an emphasis on its potential to serve as a resistance-focused alternative, its oral administration, and its novel antimicrobial target. Methods: A narrative literature search was conducted using PubMed, Google Scholar, and Scopus to identify relevant studies published between 2016 and 2026. Randomized clinical trials, systematic reviews, narrative reviews, and international guidelines from the WHO, ECDC, and CDC were included. Literature selection was guided by SANRA. Results: A single 3-g oral dose of zoliflodacin appears to exhibit high microbiological cure rates for uncomplicated urogenital and rectal gonorrhea, and it is not less effective than ceftriaxone plus azithromycin for urogenital infections, according to Phase 2 and recent global Phase 3 clinical trials, which reported mild gastrointestinal side effects. Its mechanism of action provides limited evidence of resistance and is effective against multidrug-resistant Neisseria gonorrhoeae . Conclusion: Zoliflodacin represents a potentially effective oral alternative to the current ceftriaxone-based regimen for gonorrhea. With routine observation and careful stewardship, these findings may contribute significantly to the expansion of future treatment strategies.
- 14 May 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (6) , 3404-3410
Open AccessZoliflodacin for uncomplicated gonorrhea: clinical evidence and implications beyond ceftriaxone plus azithromycin
Background: Globally, gonorrhea remains a common sexually transmitted infection that can lead to serious sexual and reproductive health complications if left untreated. Management has become more challenging due to the rapid progression of antimicrobial resistance in Neisseria gonorrhoeae . Currently, ceftriaxone-based regimens continue to be the standard treatment; however, the sudden demand for new treatment options is highlighted by concerns regarding resistance, the requirement for intramuscular administration, and the declining effectiveness of azithromycin. Objective: This review aims to evaluate the emerging role of zoliflodacin in the treatment of gonorrhea, with an emphasis on its potential to serve as a resistance-focused alternative, its oral administration, and its novel antimicrobial target. Methods: A narrative literature search was conducted using PubMed, Google Scholar, and Scopus to identify relevant studies published between 2016 and 2026. Randomized clinical trials, systematic reviews, narrative reviews, and international guidelines from the WHO, ECDC, and CDC were included. Literature selection was guided by SANRA. Results: A single 3-g oral dose of zoliflodacin appears to exhibit high microbiological cure rates for uncomplicated urogenital and rectal gonorrhea, and it is not less effective than ceftriaxone plus azithromycin for urogenital infections, according to Phase 2 and recent global Phase 3 clinical trials, which reported mild gastrointestinal side effects. Its mechanism of action provides limited evidence of resistance and is effective against multidrug-resistant Neisseria gonorrhoeae . Conclusion: Zoliflodacin represents a potentially effective oral alternative to the current ceftriaxone-based regimen for gonorrhea. With routine observation and careful stewardship, these findings may contribute significantly to the expansion of future treatment strategies.
- Open Access
- 24 April 2026
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 59 (4) , 186-187
Pleural Sealants in Pneumothorax Surgery: A Step Forward or Added Expense?
Aliza Ahmed, M.B.B.S., Muhammad Hassan Saeed, M.B.B.S.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.26.032
- 24 April 2026
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 59 (4) , 186-187
Open AccessPleural Sealants in Pneumothorax Surgery: A Step Forward or Added Expense?
Aliza Ahmed, M.B.B.S., Muhammad Hassan Saeed, M.B.B.S.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.26.032
- Open Access
- 11 March 2026
- Published by Wiley
Silent high-risk atherosclerotic plaque in asymptomatic patients: bridging the gap in preventive cardiology
To the Editor, We read with interest the recent study by Masini et al. 1 demonstrating that high-risk plaque features including ulceration, lipid rich necrotic cores and intraplaque hemorrhage, are present in many of the asymptomatic patients with intermediate cardiac stenosis, and have been linked to covert brain infarcts. These findings highlight a critical gap in traditional risk assessment, which mostly depends on stenosis severity and standard cardiovascular risk scores.
- 11 March 2026
- Published by Wiley
Open AccessSilent high-risk atherosclerotic plaque in asymptomatic patients: bridging the gap in preventive cardiology
To the Editor, We read with interest the recent study by Masini et al. 1 demonstrating that high-risk plaque features including ulceration, lipid rich necrotic cores and intraplaque hemorrhage, are present in many of the asymptomatic patients with intermediate cardiac stenosis, and have been linked to covert brain infarcts. These findings highlight a critical gap in traditional risk assessment, which mostly depends on stenosis severity and standard cardiovascular risk scores.
- Open Access
- 26 February 2026
- Published by Wiley
Climate-Driven Wildfire Smoke and the Expanding Scope of Canadian Respiratory Therapists: Are We Prepared for a New Public Health Era? Commentary
A document by Aliza Ahmed . Click on the document to view its contents.
- 26 February 2026
- Published by Wiley
Open AccessClimate-Driven Wildfire Smoke and the Expanding Scope of Canadian Respiratory Therapists: Are We Prepared for a New Public Health Era? Commentary
A document by Aliza Ahmed . Click on the document to view its contents.
- 18 November 2025
- Published by Springer Nature in Clinical Rheumatology
- Vol. 45 (1) , 615-616
Letter to the Editor regarding “Comparative analysis of clinical features in diffuse and focal enlargement of IgG4-related autoimmune pancreatitis: a single-center retrospective study”
- 18 November 2025
- Published by Springer Nature in Clinical Rheumatology
- Vol. 45 (1) , 615-616
Letter to the Editor regarding “Comparative analysis of clinical features in diffuse and focal enlargement of IgG4-related autoimmune pancreatitis: a single-center retrospective study”